Page last updated: 2024-09-05

lenalidomide and Psoriasis Arthropathica

lenalidomide has been researched along with Psoriasis Arthropathica in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Badros, A; Deng, A; Gaspari, A; Harvey, V; Junkins-Hopkins, JM; Oghilikhan, M; Samuels, A; Sina, B; Strobel, D	1

Other Studies

1 other study(ies) available for lenalidomide and Psoriasis Arthropathica

Article	Year
Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors. Archives of dermatology, 2006, Volume: 142, Issue:2 Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Biopsy; Diagnosis, Differential; Drug Eruptions; Etanercept; Female; Follow-Up Studies; Humans; Immunoglobulin G; Infliximab; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Skin; Thalidomide; Tumor Necrosis Factor-alpha	2006

Article

Year

Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors.

Archives of dermatology, 2006, Volume: 142, Issue:2

Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Biopsy; Diagnosis, Differential; Drug Eruptions; Etanercept; Female; Follow-Up Studies; Humans; Immunoglobulin G; Infliximab; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Skin; Thalidomide; Tumor Necrosis Factor-alpha

2006